Jeffrey Becker
Gründer bei Bexson Biomedical, Inc.
Profil
Jeffrey Becker is the founder of Bexson Biomedical, Inc. He currently works as a Venture Partner at Noetic Psychedelic.
He completed his undergraduate degree at UC Berkeley School of Public Health.
Aktive Positionen von Jeffrey Becker
| Unternehmen | Position | Beginn |
|---|---|---|
Bexson Biomedical, Inc.
 Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Gründer | - |
Noetic Psychedelic
 Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Private Equity Investor | - |
Ausbildung von Jeffrey Becker
| UC Berkeley School of Public Health | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Finance |
Bexson Biomedical, Inc.
Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Health Technology |
